FDA Approved: SOTYKTU — Original Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved SOTYKTU (deucravacitinib) from its original application (NDA214958) by E.R. Squibb & Sons, L.L.C. for the treatment of plaque psoriasis. This marks…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

ORIG AP for SOTYKTU (DEUCRAVACITINIB)